Douglas Pharmaceuticals has gained Food and Drug Administration
(FDA) approval to sell its New Zealand-developed acne drug,
isotretinoin. The first US orders will be dispatched next month
with a consumer launch to follow around April-May.
"This is a huge breakthrough for us and for New Zealand which
will benefit from the increased export earnings," said Douglas
Pharmaceuticals director Jeff Douglas.
"We believe our isotretinoin is the first NZ-developed human
medicine to be approved for use in the US. It's our biggest export
product and is the market leader in Spain, Austria, Germany and
Mexico. The US market has, however, taken a little longer to get
approval but as the US is the largest pharmaceutical market in the
world the potential for us is very exciting."
Isotretinoin is sold as a prescription-medicine in New Zealand
under the brand name Oratane.
--Idealog--
Read full article
